| Glycometabolic |
Blood vessels |
DSPE-PEG-RGD (Arg–Gly–Asp) |
X |
187
|
| Genetic |
Neurons, microglia and oligodendrocytes in the brain |
RVG (Rabies Virus Glycoprotein)-Lamp2b (lysosome-associated membrane protein 2b) |
Alzheimer's disease |
189
|
| Genetic |
Brain |
RVG (Rabies Virus Glycoprotein)-Lamp2b (lysosome-associated membrane protein 2b) |
Ischemic stroke |
190
|
| Genetic |
Chronic myelogenous leukemia (CML) cells |
Fragment of interlukin 3 (IL-3) |
Acute myeloid leukemia |
191
|
| Genetic |
B lymphocytes |
CD 19 chimeric antigen receptor |
Hematological malignant diseases |
193
|
| Genetic |
Liver cancer cells |
Pre S1 as a targeting moiety for sodium taurocholate cotransporting polypeptide (NTCP) |
Liver cancer |
194
|
| Glycometabolic |
Activated macrophages (M1) |
Dextran sulfate (DS) as a targeting moiety for macrophage scavenger receptor class A (SR-A) |
Rheumatoid arthritis |
196
|
| Glycometabolic |
4T1 |
CD 47 |
Breast cancer |
197
|
